MAIA Labs is a Czech DeepTech startup founded in 2022 in Brno, developing artificial intelligence for endoscopy. Our flagship product ColoMAIA helps physicians detect polyps and suspicious findings in real time during colonoscopy, automate documentation, and improve examination quality.
A brief but celebrated journey.
Founded in Brno, Czech Republic, with a mission to revolutionize endoscopy through artificial intelligence.
Winner of the program supporting innovative technology projects and prototype validation.
Florida, USA — Winner with Best Idea for Use Case for innovative AI in healthcare.
Grand Winner — overall victor of the most prestigious startup competition in the Czech Republic.
Winner for the best digital innovation in healthcare.
Winner of the regional startup competition in Central Europe.
Winner for innovative use of artificial intelligence in clinical practice.
Winner among the world's best startups.
Launch of comprehensive multicenter clinical trial to validate ColoMAIA II effectiveness and safety across diverse clinical settings. Trial continues into 2026.
Installation of ColoMAIA II at Mayo Clinic Florida, USA — a major milestone in North American deployment.
Obtained CE mark under the Medical Device Regulation (MDR), enabling distribution across European markets.
FDA clearance process initiated for ColoMAIA II. Expected clearance 2026.




MAIA Labs is a Brno-based company founded in 2022 developing artificial intelligence for endoscopy and has earned numerous prestigious international awards in a remarkably short time.